LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma

Despite clinical advances in diagnosis and treatment, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death, and is still associated with poor prognosis and dismal survival rates. Identifying novel PDAC-targeted tools to tackle these unmet clinical needs is thus an...

Descripción completa

Detalles Bibliográficos
Autores principales: Acier, Angélina, Godard, Magali, Gassiot, Fanny, Finetti, Pascal, Rubis, Marion, Nowak, Jonathan, Bertucci, François, Iovanna, Juan L., Tomasini, Richard, Lécorché, Pascaline, Jacquot, Guillaume, Khrestchatisky, Michel, Temsamani, Jamal, Malicet, Cédric, Vasseur, Sophie, Guillaumond, Fabienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377056/
https://www.ncbi.nlm.nih.gov/pubmed/34413441
http://dx.doi.org/10.1038/s42003-021-02508-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377056/
https://www.ncbi.nlm.nih.gov/pubmed/34413441
http://dx.doi.org/10.1038/s42003-021-02508-0

Ejemplares similares